| Income Statement |
| Total Revenue | 105.95M |
|
| Revenues (USD) | 105.95M |
| Cost of Revenue | 46.09M |
| Gross Profit | 59.86M |
| Operating Expenses | 50.18M |
| Research and Development Expense | 24.51M |
| Selling, General and Administrative Expense | 25.67M |
| Operating Income | 9.67M |
| Interest Expense | 40.81M |
| Income Tax Expense | -44.00K |
| Net Income | 1.03M |
| Net Income Common Stock | 1.03M |
| Net Income Common Stock (USD) | 1.03M |
| Consolidated Income | 1.03M |
| Earning Before Interest & Taxes (EBIT) | 41.79M |
| Earning Before Interest & Taxes (USD) | 41.79M |
| Weighted Average Shares | 312.02M |
| Balance Sheet |
| Cash and Equivalents | 63.83M |
| Cash and Equivalents (USD) | 63.83M |
| Trade and Non-Trade Receivables | 48.49M |
| Current Assets | 455.98M |
| Property, Plant & Equipment Net | 495.23M |
| Total Assets | 1.42B |
| Debt Current | 55.64M |
| Total Debt | 1.46B |
| Current Liabilities | 259.78M |
| Debt Non-Current | 1.40B |
| Total Liabilities | 1.70B |
| Accumulated Retained Earnings (Deficit) | -2.41B |
| Accumulated Other Comprehensive Income | 401.00K |
| Shareholders Equity | -282.31M |
| Shareholders Equity (USD) | -282.31M |
| Assets Non-Current | 965.19M |
| Total Debt (USD) | 1.46B |
| Deferred Revenue | 22.68M |
| Goodwill and Intangible Assets | 132.11M |
| Inventory | 228.02M |
| Liabilities Non-Current | 1.44B |
| Trade and Non-Trade Payables | 97.87M |
| Tax Assets | 192.86M |
| Tax Liabilities | 9.21M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 10.29M |
| Net Cash Flow from Financing | -967.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -107.59M |
| Capital Expenditure | -7.14M |
| Issuance (Repayment) of Debt Securities | -967.00K |
| Net Cash Flow from Investing | -46.19M |
| Net Cash Flow from Operations | -25.25M |
| Effect of Exchange Rate Changes on Cash | -936.00K |
| Share Based Compensation | 2.34M |